Skip to main content

15-09-2017 | Non-small-cell lung cancer | ESMO 2017 | Video

NSCLC highlights from ESMO 2017

ESMO expert Floriana Morgillo provides independent comment on the PACIFIC, FLAURA, and IFCT-0302 trials, the focus of the first Presidential symposium.

Enriched treatment pathway for non-driver NSCLC

What is it and why do I need it?

Image Credits